Expression of lymphocyte activation gene-3 on CD4
CD4(+)T cell
IL-18
LAG-3
Myasthenia gravis
Journal
Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498
Informations de publication
Date de publication:
15 03 2024
15 03 2024
Historique:
received:
01
10
2023
revised:
18
01
2024
accepted:
31
01
2024
medline:
8
3
2024
pubmed:
8
2
2024
entrez:
7
2
2024
Statut:
ppublish
Résumé
Myasthenia gravis (MG) is a T cell-dependent, B cell-mediated, and complement-dependent autoimmune disease. Lymphocyte activation gene-3 (LAG-3; CD223) is an immune checkpoint protein that plays an important role in maintaining autoimmune tolerance and homeostasis. To investigate the cytokine-regulated expression pattern of LAG-3, CD4
Identifiants
pubmed: 38325197
pii: S0165-5728(24)00026-2
doi: 10.1016/j.jneuroim.2024.578308
pii:
doi:
Substances chimiques
Cytokines
0
Interleukin-18
0
Lag3 protein, human
0
IL18 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
578308Informations de copyright
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All of the authors declare that there are no conflicts of interest.